These novel treatments, Tirzepatide , represent a remarkable advancement in treating metabolic dysfunction and possibly other ailments . These drugs are classified as GLP-1 hormone agonists , meaning they function to mimic the endogenous GLP-1 hormone , enhancing insulin secretion and lowering fo